Qube Research & Technologies (QRT)
IRWD icon

Qube Research & Technologies (QRT)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
347,985
-1,242,096
-78% -$4.79M ﹤0.01% 2257
2026
Q1 		$5.58M Sell
1,590,081
-91,148
-5% -$374K 0.01% 1590
2025
Q4 		$5.67M Sell
1,681,229
-1,125,681
-40% -$2.92M 0.01% 1690
2025
Q3 		$3.68M Sell
2,806,910
-544,092
-16% -$563K ﹤0.01% 1932
2025
Q2 		$2.4M Buy
3,351,002
+43,943
+1% +$34.5K ﹤0.01% 2125
2025
Q1 		$4.86M Buy
3,307,059
+3,049,329
+1,183% +$7.26M 0.01% 1555
2024
Q4 		$1.14M Sell
257,730
-313,045
-55% -$1.27M ﹤0.01% 2117
2024
Q3 		$2.35M Buy
+570,775
New +$3.07M ﹤0.01% 1703
2024
Q1 		– Sell
-79,168
Closed -$906K – 4671
2023
Q4 		$906K Buy
+79,168
New +$783K ﹤0.01% 1982
2023
Q3 		– Sell
-258,308
Closed -$2.75M – 4209
2023
Q2 		$2.75M Buy
258,308
+52,000
+25% +$559K 0.01% 917
2023
Q1 		$2.17M Buy
206,308
+36,014
+21% +$403K 0.01% 977
2022
Q4 		$2.11M Buy
170,294
+36,763
+28% +$417K 0.01% 933
2022
Q3 		$1.38M Sell
133,531
-13,494
-9% -$153K 0.01% 1077
2022
Q2 		$1.7M Buy
147,025
+90,885
+162% +$1.07M 0.01% 881
2022
Q1 		$706K Sell
56,140
-100,655
-64% -$1.15M 0.01% 1356
2021
Q4 		$1.83M Buy
156,795
+88,294
+129% +$1.08M 0.01% 884
2021
Q3 		$895K Buy
+68,501
New +$885K 0.01% 948
2021
Q1 		– Sell
-69,532
Closed -$792K – 2155
2020
Q4 		$792K Buy
+69,532
New +$761K 0.01% 951
2020
Q3 		– Sell
-54,505
Closed -$562K – 1892
2020
Q2 		$562K Buy
54,505
+38,311
+237% +$392K 0.01% 1069
2020
Q1 		$163K Buy
16,194
+3,931
+32% +$46.2K 0.01% 907
2019
Q4 		$163K Buy
+12,263
New +$135K 0.01% 1424

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Qube Research & Technologies (QRT)'s IRWD Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Ironwood Pharmaceuticals (IRWD) stake by 78% in Q2 2026, selling an estimated $4.79M and leaving 347,985 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

Qube Research & Technologies (QRT) first reported a position in IRWD in Q4 2019 and has held it in 21 quarters since. The position peaked at $5.67M in Q4 2025. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Qube Research & Technologies (QRT) held 347,985 shares of Ironwood Pharmaceuticals worth $1.47M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 1,242,096 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $4.79M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2257 holding.
  • Qube Research & Technologies (QRT) first reported a position in Ironwood Pharmaceuticals in Q4 2019 and has held it in 21 quarters since.
  • Qube Research & Technologies (QRT)'s Ironwood Pharmaceuticals position peaked at $5.67M in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.